Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19
Condition(s):COVID-19; Acute Respiratory Distress Syndrome; Severe Acute Respiratory Syndrome (SARS); Coronavirus InfectionsLast Updated:January 26, 2022Terminated
Hide Studies Not Open or Pending
Condition(s):COVID-19; Acute Respiratory Distress Syndrome; Severe Acute Respiratory Syndrome (SARS); Coronavirus InfectionsLast Updated:January 26, 2022Terminated
Condition(s):COVID; Corona Virus Infection; COVID19Last Updated:December 20, 2022Terminated
Condition(s):Coronavirus Infections; Diabetes Mellitus; Prevalence; Risk Factors; Patient Outcome Assessment; Severe Acute Respiratory SyndromeLast Updated:June 2, 2020Unknown status
Condition(s):COVID-19Last Updated:April 28, 2023Recruiting
Condition(s):Health Care Worker Patient Transmission; Coronavirus; Coronavirus Infections; Immunological AbnormalityLast Updated:February 22, 2022Unknown status
Condition(s):COVID-19Last Updated:October 9, 2020Completed
Condition(s):Vaccination HesitancyLast Updated:October 12, 2023Not yet recruiting
Condition(s):Post-COVID-19 SyndromeLast Updated:August 14, 2023Completed
Condition(s):COVID-19Last Updated:October 29, 2021Completed
Condition(s):SARS-CoV-2; COVID-19; Vaccines; AntibodyLast Updated:October 20, 2021Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.